First-in-human evaluation of a novel magnetic apnea prevention (Magnap) device for obstructive sleep apnea (OSA) treatment was disrupted by the COVID-19 pandemic which negatively impacted the ability to track patient outcomes with in-lab polysomnograms (PSG). The objective of this study is to report the modifications undertaken in response to COVID-19 and to discuss the feasibility of home sleep apnea testing (HSAT) to monitor novel OSA therapies....

We were challenged during the pandemic in many ways and the researchers did focus mainly on mental and physical health primarily of adults, as referred to be more at risk by the virus, yet we thought that is was essential to study how the pandemic impacted the most fragile life stages, those of the children, referring to the sleep hygiene....

I am writing to highlight to the community involved in the research and management of Restless Legs Syndrome (RLS), the need for some clarity and an evidence-based rationale for the selection of a “cut off” value of serum ferritin concentrations in the decision regarding the use of intravenous (IV) iron infusion in the treatment of RLS....